EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
08.07.26
/
50%
€12.20
Target price
08.07.27
€41.17
Performance (%)
-0.82%
Price
15.07.26
€11.80
Summary
This prediction is currently active. Since the start of the prediction for EyePoint Pharmaceuticals Inc. the price has only changed by -0.82%. This prediction currently runs until 08.07.27. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| EyePoint Pharmaceuticals Inc. | 0.855% |
| iShares Core DAX® | -0.097% |
| iShares Nasdaq 100 | 0.585% |
| iShares Nikkei 225® | -0.055% |
| iShares S&P 500 | 0.939% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $47.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.48
20.06.24
20.06.24
-
20.06.25
20.06.25
-6.79%
21.06.25
21.06.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
14.09.23
14.09.23
€29.02
14.09.24
14.09.24
-18.55%
15.09.24
15.09.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-13.24%
01.09.24
01.09.24

